NY S 9852
in committeeRelates to designated or rescheduled drugs
New York · 2025-2026 Regular Session · upper
Quick answers
Did NY S 9852 pass?
Not yet. NY S 9852 is in committee as of 2026-04-08 and has not come to a final vote. Latest recorded action (2026-04-08): REFERRED TO HEALTH
What is NY S 9852 about?
Provides that when a drug is designated or rescheduled by the federal government, it shall be deemed scheduled under NYS law automatically, without further action by the commissioner.
Who sponsors NY S 9852?
Jessica Scarcella-Spanton is the primary sponsor of NY S 9852.
Description
Provides that when a drug is designated or rescheduled by the federal government, it shall be deemed scheduled under NYS law automatically, without further action by the commissioner.
- Introduced
- —
- Latest action
- 2026-04-08 — REFERRED TO HEALTH
- Bill type
- bill
- Last updated
- —
Sponsors
- Jessica Scarcella-Spantonprimary
Committees
Not provided by source.
Action timeline
2026-04-08
REFERRED TO HEALTH
referral-committee
Versions
- S9852Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: A 11499
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 9852. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.